A prospective study of transfusion-transmitted GB virus C infection: Similar frequency but different clinical presentation compared with hepatitis C virus

Blood

Volumn 88, Issue 5, 1996, Pages 1881-1886

  Wang, Jin Town ^b   Tsai, Feng Chiao ^b   Lee, Cha Ze ^b   Chen, Pei Jer ^b   Sheu, Jin Chuan ^b   Wang, Teh Hong ^b   Chen, Ding Shinn ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD TRANSFUSION; CLINICAL FEATURE; DISEASE TRANSMISSION; HEART SURGERY; HEPATITIS C VIRUS; HUMAN; PRIORITY JOURNAL;

EID: 84984568823     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.5.1881.1881     Document Type: Article

References (23)

1. Japanese Red Cross Non-A, Non-B Hepatitis Research Group: Effect of screening for hepatitis C virus antibody and hepatitis B virus core antibody on incidence of posttransfusion hepatitis. Lancet 338:1040, 1991
2. Donahue JG, Munoz A, Ness PM, Brown DE Jr, Yawn DH, McAllister HA Jr, Reitz BA, Nelson KE: The declining risk of posttransfusion hepatitis C virus infection. N Engl J Med 327:369, 1992
3. Deinhardt F, Holmes AW, Capps, RB, Popper H: Studies on the transmission of disease of human viral hepatitis to marmoset monkeys. I. Transmission of disease, serial passages and description of liver lesions. J Exp Med 125:673, 1967
4. Simons JN, Pilot-Matias TJ, Leary TP, Dawson GJ, Desai SM, Schlauder GG, Muerhoff AS, Erker JC, Bujik SI, Chalmers ML, VanSant CL, Mushahwar IK: Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci USA 92:3401, 1995
5. Schlauder GG, Dawson GJ, Simons JN, Pilot-Matias TJ, Gutierrez RA, Heynen CA, Knigge MF, Kurpiewski GS, Bujik SL, Leary TP, Muerhoff AS, Desai SM, Mushahwar IK: Molecular and serologic analysis in the transmission of the GB hepatitis agents. J Med Virol 46:81, 1995
6. Muerhoff AS, Leary TP, Simons JN, Pilot-Matias TJ, Dawson GJ, Erker JC, Chalmers ML, Schlauder GG, Desai SM, Mushahwar IK: Genomic organization of GB viruses A and B: Two new members of the Flaviviridae associated with GB agent hepatitis. J Virol 69:5621, 1995
7. Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, Desai SM, Mushahwar IK: Isolation of novel virus-like sequences associated with human hepatitis. Nature Med 1:564, 1995
8. Wang TH, Wang JT, Lin JT, Sheu JC, Sung JL, Chen DS: A prospective study of posttransfusion hepatitis in Taiwan. J Hepatol 13:38, 1991
9. Linnen J, Wages J Jr, Zhang-Keck ZY, Fry KE, Krawczynski KZ, Alter H, Koonin E, Gallagher M, Alter M, Hadziyannis S, Karayiannis P, Fung K, Nakatsji Y, Shih JW-K, Young L, Piatak M Jr, Hoover C, Fernandez J, Chen S, Zou J-C, Morris T, Hyams KC, Ismay S, Lifson JD, Hess G, Foung SKH, Thomas H, Bradley D, Margolis H, Kim JP: Molecular cloning and disease association of hepatitis G virus: A transfusion-transmissible agent. Science 271:505, 1996
10. Wang JT, Wang TH, Sheu JC, Lin JT, Wang CY, Chen DS: Posttransfusion hepatitis revisited by hepatitis C antibody assays and polymerase chain reaction. Gastroenterology 103:609, 1992
11. Wang JT, Lin MT, Chen PJ, Sheu JC, Lin JT, Wang TH, Chen DS: Transfusion-transmitted human T-cell lymphotropic virus type I infection in Taiwan: A true risk and occasional coinfection with hepatitis C virus shown in a prospective study. Blood 84:934, 1994
12. Wang JT, Wang TH, Sheu JC, Lin SM, Lin JT, Chen DS: Effects of anticoagulants and storage of blood samples on efficacy of the polymerase chain reaction assay for hepatitis C virus. J Clin Microbiol 30:750, 1992
13. Wang JT, Wang TH, Sheu JC, Shih LN, Lin JT, Chen DS: Detection of hepatitis B virus DNA by polymerase chain reaction in plasma of volunteer blood donors negative for hepatitis B surface antigen. J Infect Dis 163:397, 1991
14. Sayers MH: Transfusion-transmitted viral infections other than hepatitis and human immunodeficiency virus infection, cytomegalovirus, Epstein-Barr virus, human herpesvirus 6, and human parvovirus B19. Arch Path Lab Med 118:346, 1994
15. Wylie BR: Transfusion transmitted infection: viral and exotic disease. Anaesth Intensive Care 21:24, 1993
16. Yoshiba M, Okamoto H, Mishiro S: Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet 346:1131, 1995
17. Ulrich PP, Bhat RA, Seto B, Mack D, Sninsky J, Vyas GN: Enzymatic amplication of hepatitis B virus DNA in serum compared with infectivity testing in chimpanzees. J Infect Dis 160:37, 1989
18. Brown KE, Green SW, Antunez de Mayolo J, Bellanti JA, Smith SD, Smith TJ, Young NS: Congenital anaemia after transplacental B19 parvovirus infection. Lancet 343:895, 1994
19. Tokudome S, Tokunaga O, Shimamoto Y, Miyamoto Y, Sumida I, Kikuchi M, Takeshita M, Ikeda T, Fujiwara K, Yoshihara M: Incidence of adult T-cell leukemia/lymphoma among human T-lymphotrophic virus type I carriers in Saga, Japan. Cancer Res 49:226, 1989
20. Hjelle B: Human T-cell leukemia/lymphoma viruses. Life cycle, pathogenecity, epidemiology, and diagnosis. Arch Pathol Lab Med 115:440, 1991
21. Manns A, Blattner WA: The epidemiology of the human T-cell lymphotropic virus type I and type II: Etiologic role in human disease. Transfusion 31:67, 1991
22. Gout O, Baulac M, Gessain A, Semah F, Saal F, Peries J, Cabrol C, Foucault-Fretz C, Laplane D, Sigaux F, de The G: Rapid development of myelopathy after HTLV-I infection acquired by transfusion during cardiac transplantation. N Engl J Med 322:383, 1990
23. Kaplan JE, Litchfield B, Rouault C, Lairmore MD, Luo CC, Williams L, Brew BJ, Price RW, Janssen R, Stoneburner R, Ou CY, Folks T, De B: HTLV-I-associated myelopathy associated with blood transfusion in the United States: Epidemiologic and molecular evidence linking donor and recipient. Neurology 41:192, 1991